Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LifeMD, Inc. Director's Dealing 2018

Oct 25, 2018

33298_dirs_2018-10-25_73c0f494-2366-4827-afb7-ed6f3bac68b7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONVERSION LABS, INC. (CVLB)
CIK: 0000948320
Period of Report: 2018-09-12

Reporting Person: DiTrolio Joseph (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-09-12 Common Stock, par value $0.01 P 5000 $0.27 Acquired 77500 Direct
2018-09-12 Common Stock, par value $0.01 P 5000 $0.2606 Acquired 82500 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-10-16 Option $0.20 J 352500 Acquired 2023-10-12 Common Stock , par value $0.01 (352500) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Option $0.20 2022-09-12 Common Stock , par value $0.01 (100000) 100000 Direct
Option $0.20 2024-09-04 Common Stock , par value $0.01 (250000) 250000 Direct
Option $0.40 2024-09-04 Common Stock, par value $0.01 (125000) 125000 Direct
Option $0.35 2027-07-01 Common Stock , par value $0.01 (125000) 100000 Direct

Footnotes

F1: The 352,500 options were assigned to the Reporting Person by a third party as consideration for consulting services.